Atara Biotherapeutics (ATRA) Q3 2022 Earnings Report

0 Followers

CH:ATRA Q3 2022 EPS Results

Actual EPS: -CHF 17.06
Consensus EPS: -CHF 15.51
Beat/Miss: Missed by -CHF 1.55
One Year Ago EPS: -CHF 18.73

CH:ATRA Q3 2022 Revenue Results

Actual Revenue: CHF 3.71M
Expected Revenue: CHF 4.27M
Beat/Miss: Missed by -CHF 560.94K
YoY Revenue Growth: -16.96%

Earnings Announcement Details

Quarter: Q3 2022
Date: 11/08/2022
Time: After Close
Conference Call: Tuesday, November 8, 2022

CH:ATRA Upcoming Earnings

Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

CH:ATRA Q3 2022 Earnings Call

0:00 / 0:00

Q3 2022 Earnings Slide Deck

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:ATRA Earnings History

CH:ATRA earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 01, 2027	2026 (Q4)	-0.08-	-0.21	―	―
Nov 10, 2026	2026 (Q3)	-0.11-0.12	-0.27	53.13% (+0.14)
Aug 12, 2026	2026 (Q2)	-0.26-0.27	0.16	-268.42% (-0.42)
May 12, 2026	2026 (Q1)	-0.27-0.24	2.91	-108.29% (-3.15)
Mar 16, 2026	2025 (Q4)	-0.15-0.21	-0.99	78.99% (+0.78)
Nov 29, 2025	2025 (Q3)	-0.55-0.27	-2.44	89.08% (+2.17)
Aug 11, 2025	2025 (Q2)	-0.050.16	-2.58	106.13% (+2.74)
May 15, 2025	2025 (Q1)	-1.652.91	-4.79	160.87% (+7.70)
Mar 07, 2025	2024 (Q4)	-2.38-0.99	-11.65	91.50% (+10.66)
Nov 12, 2024	2024 (Q3)	-1.57-2.44	-13.73	82.24% (+11.29)
Aug 12, 2024	2024 (Q2)	-1.86-2.58	-14.15	81.76% (+11.57)
May 08, 2024	2024 (Q1)	-5.34-4.79	-14.98	68.06% (+10.20)
Mar 28, 2024	2023 (Q4)	-9.26-11.65	-14.98	22.22% (+3.33)
Nov 01, 2023	2023 (Q3)	-12.96-13.73	-17.06	19.51% (+3.33)
Aug 08, 2023	2023 (Q2)	-13.65-14.15	3.75	-477.78% (-17.89)
May 08, 2023	2023 (Q1)	-7.71-14.98	-18.1	17.24% (+3.12)
Feb 08, 2023	2022 (Q4)	-10.81-14.98	-19.97	25.00% (+4.99)
Nov 08, 2022	2022 (Q3)	-15.51-17.06	-18.73	8.89% (+1.66)
Aug 08, 2022	2022 (Q2)	-16.563.75	-18.93	119.78% (+22.68)
May 05, 2022	2022 (Q1)	-19.40-18.10	-17.89	-1.16% (-0.21)
Feb 28, 2022	2021 (Q4)	-14.44-19.97	-19.77	-1.05% (-0.21)
Nov 04, 2021	2021 (Q3)	-18.77-18.73	-19.14	2.17% (+0.42)
Aug 09, 2021	2021 (Q2)	-18.16-18.93	-23.72	20.18% (+4.79)
May 04, 2021	2021 (Q1)	―-17.89	-24.97	28.33% (+7.07)
Mar 01, 2021	2020 (Q4)	―-19.77	-28.3	30.15% (+8.53)
Nov 09, 2020	2020 (Q3)	―-19.14	-27.26	29.77% (+8.11)
Aug 05, 2020	2020 (Q2)	―-23.72	-33.29	28.75% (+9.57)
May 06, 2020	2020 (Q1)	―-1.00	-1.2	16.67% (+0.20)
Feb 27, 2020	2019 (Q4)	―-1.13	-1.46	22.29% (+0.32)
Nov 07, 2019	2019 (Q3)	―-1.09	-1.07	-1.55% (-0.02)
Aug 08, 2019	2019 (Q2)	―-1.33	-0.96	-39.13% (-0.37)
May 09, 2019	2019 (Q1)	―-1.20	-0.87	-37.14% (-0.32)
Feb 26, 2019	2018 (Q4)	―-1.46	-0.96	-52.17% (-0.50)
Nov 06, 2018	2018 (Q3)	―-1.07	-0.85	-26.47% (-0.22)
Aug 01, 2018	2018 (Q2)	―-0.96	-0.78	-22.34% (-0.17)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Atara Biotherapeutics earnings date